PUBLICATION

phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development

Authors
Lawson, N.D., Mugford, J.W., Diamond, B.A., and Weinstein, B.M.
ID
ZDB-PUB-030717-17
Date
2003
Source
Genes & Development   17(11): 1346-1351 (Journal)
Registered Authors
Diamond, Brianne, Lawson, Nathan, Mugford, Joshua, Weinstein, Brant M.
Keywords
none
MeSH Terms
  • Animals, Genetically Modified
  • Embryo, Nonmammalian/physiology
  • Female
  • Phospholipase C gamma
  • Animals
  • Muscle, Smooth, Vascular/cytology
  • Muscle, Smooth, Vascular/embryology
  • Endothelial Growth Factors/genetics*
  • Zebrafish/embryology*
  • Intercellular Signaling Peptides and Proteins/genetics*
  • Genetic Carrier Screening
  • Crosses, Genetic
  • Vascular Endothelial Growth Factor A
  • Gene Expression Regulation, Developmental*
  • DNA Primers
  • Polymerase Chain Reaction
  • Male
  • Lymphokines/genetics*
  • Base Sequence
  • Type C Phospholipases/genetics*
  • Type C Phospholipases/metabolism
  • Molecular Sequence Data
  • Arteries/cytology
  • Arteries/embryology*
  • Recombinant Proteins/metabolism
  • Vascular Endothelial Growth Factors
  • RNA, Messenger/genetics
PubMed
12782653 Full text @ Genes & Dev.
Abstract
In this study, we utilize transgenic zebrafish with fluorescently labeled blood vessels to identify and characterize a mutant (y10) that displays specific defects in the formation of arteries, but not veins. We find that y10 encodes phospholipase C gamma-1 (plcg1), a known effector of receptor tyrosine kinase signaling. We further show that plcg1y10 mutant embryos fail to respond to exogenous Vegf. Our results indicate that Plcg1 functions specifically downstream of the Vegf receptor during embryonic development to govern formation of the arterial system.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping